[1] M. Aznab, Evaluation of COVID 19 infection in 279 cancer patients treated during a 90-day period in 2020 pandemic, International journal of clinical oncology, 25 (2020) 1581-1586.
[2] P.S. Becker, E.A. Griffiths, L.M. Alwan, K. Bachiashvili, A. Brown, R. Cool, P. Curtin, S. Dinner, I. Gojo, A. Hicks, A. Kallam, W.Z. Kidwai, D.D. Kloth, E.H. Kraut, D. Landsburg, G.H. Lyman, R. Miller, S. Mukherjee, S. Patel, L.E. Perez, A. Poust, R. Rampal, R. Rosovsky, V. Roy, H.S. Rugo, S. Shayani, S. Vasu, M. Wadleigh, K. Westbrook, P. Westervelt, J. Burns, J. Keller, L.A. Pluchino, NCCN Guidelines Insights: Hematopoietic Growth Factors, Version 1.2020, Journal of the National Comprehensive Cancer Network : JNCCN, 18 (2020) 12-22.
[3] S. Bossoni, L. Chiesa, A. Giustina, Severe hypocalcemia in a thyroidectomized woman with Covid-19 infection, Endocrine, 68 (2020) 253-254.
[4] N. Chen, M. Zhou, X. Dong, J. Qu, F. Gong, Y. Han, Y. Qiu, J. Wang, Y. Liu, Y. Wei, Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study, The Lancet, 395 (2020) 507-513.
[5] N. China, New Coronavirus Pneumonia Prevention and Control Protocol, in, National Health Commission of the People's Republic of China, 2020.
[6] K. de Joode, D.W. Dumoulin, J. Tol, H.M. Westgeest, L.V. Beerepoot, F.W. van den Berkmortel, P.G. Mutsaers, N.G. van Diemen, O.J. Visser, E. Oomen-de Hoop, Dutch Oncology COVID-19 consortium: Outcome of COVID-19 in patients with cancer in a nationwide cohort study, European Journal of Cancer, 141 (2020) 171-184.
[7] ESMO, CANCER PATIENT MANAGEMENT DURING THE COVID-19 PANDEMIC, (2020).
[8] S. Ganatra, S.S. Dani, R. Redd, K. Rieger-Christ, R. Patel, R. Parikh, A. Asnani, V. Bang, K. Shreyder, S.S. Brar, Outcomes of COVID-19 in Patients With a History of Cancer and Comorbid Cardiovascular Disease, Journal of the National Comprehensive Cancer Network, 1 (2020) 1-10.
[9] J. García-Suárez, J. de la Cruz, Á. Cedillo, P. Llamas, R. Duarte, V. Jiménez-Yuste, J.Á. Hernández-Rivas, R. Gil-Manso, M. Kwon, P. Sánchez-Godoy, P. Martínez-Barranco, B. Colás-Lahuerta, P. Herrera, L. Benito-Parra, A. Alegre, A. Velasco, A. Matilla, M.C. Aláez-Usón, R. Martos-Martínez, C. Martínez-Chamorro, K. Susana-Quiroz, J.F. Del Campo, A. de la Fuente, R. Herráez, A. Pascual, E. Gómez, J. Pérez-Oteyza, E. Ruiz, A. Alonso, J. González-Medina, L.N. Martín-Buitrago, M. Canales, I. González-Gascón, M.C. Vicente-Ayuso, S. Valenciano, M.G. Roa, P.E. Monteliu, J. López-Jiménez, C.E. Escobar, J. Ortiz-Martín, J.L. Diez-Martin, J. Martinez-Lopez, C. Serí-Merino, K. Queiroz-Cervantes, M.E. Fernandez, M.-J. Peñalva-Moreno, D. Naya-Errea, L. Bermejo-Martínez, L. Llorente-González, H. the Asociación Madrileña de Hematología y, Impact of hematologic malignancy and type of cancer therapy on COVID-19 severity and mortality: lessons from a large population-based registry study, Journal of Hematology & Oncology, 13 (2020) 133.
[10] C. Huang, Y. Wang, X. Li, L. Ren, J. Zhao, Y. Hu, L. Zhang, G. Fan, J. Xu, X. Gu, Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China, The lancet, 395 (2020) 497-506.
[11] L.Y.W. Lee, J.-B. Cazier, T. Starkey, S.E.W. Briggs, R. Arnold, V. Bisht, S. Booth, N.A. Campton, V.W.T. Cheng, G. Collins, H.M. Curley, P. Earwaker, M.W. Fittall, S. Gennatas, A. Goel, S. Hartley, D.J. Hughes, D. Kerr, A.J.X. Lee, R.J. Lee, S.M. Lee, H. McKenzie, C.P. Middleton, N. Murugaesu, T. Newsom-Davis, A.C. Olsson-Brown, C. Palles, T. Powles, E.A. Protheroe, K. Purshouse, A. Sharma-Oates, S. Sivakumar, A.J. Smith, O. Topping, C.D. Turnbull, C. Várnai, A.D.M. Briggs, G. Middleton, R. Kerr, A. Gault, M. Agnieszka, A. Bedair, A. Ghaus, A. Akingboye, A. Maynard, A. Pawsey, A.A. Mohamed, A. Okines, A. Massey, A. Kwan, A. Ferreira, A. Angelakas, A. Wu, A. Tivey, A. Armstrong, A. Madhan, A. Pillai, A. Poon-King, B. Kurec, C. Usborne, C. Dobeson, C. Thirlwell, C. Mitchell, C. Sng, C. Scrase, C. Jingree, C. Brunner, C. Fuller, C. Griffin, C. Barrington, D. Muller, D. Ottaviani, D. Gilbert, E. Tacconi, E. Copson, E. Renninson, E. Cattell, E. Burke, F. Smith, F. Holt, G. Soosaipillai, H. Boyce, H. Shaw, H. Hollis, H. Bowyer, I. Anil, J.J. Illingworth Gibson, J. Bhosle, J. Best, J. Barrett, J. Noble, J. Sacco, J. Chacko, J. Chackathayil, K. Banfill, L. Feeney, L. Horsley, L. Cammaert, L. Mukherjee, L. Eastlake, L. Devereaux, L. Melcher, L. Cook, M. Teng, M. Hewish, M. Bhattacharyya, M. Choudhury, M. Baxter, M. Scott-Brown, M. Fittall, M. Tilby, M. Rowe, M. Agnieszka, M. Alihilali, M. Galazi, N. Yousaf, N. Chopra, N. Cox, O. Chan, O. Sheikh, P. Ramage, P. Greaves, P. Leonard, P.S. Hall, P. Naksukpaiboon, P.R. Corrie Peck, R. Sharkey, R. Bolton, R. Sargent, R. Jyothirmayi, R. Goldstein, R. Oakes, R.R. Shotton Kanani, R. Board, R. Pettengell, R. Claydon, S. Moody, S. Massalha, S. Kathirgamakarthigeyan, S. Dolly, S. Derby, S. Lowndes, S. Benafif, S. Kingdon, S. Ayers, S. Brown, S. Ellis, S. Parikh, S. Pugh, S. Shamas, S. Wyatt, S. Grumett, S. Lau, Y.N.S. Wong, S. McGrath, S. Cornthwaite, S. Eeckelaers, S. Hibbs, T. Tillet, T. Rabbi, T. Robinson, T. Roques, V. Angelis, V. Woodcock, V. Brown, Y. Peng, Y. Drew, Z. Hudson, COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study, The Lancet Oncology, 21 (2020) 1309-1316.
[12] Y. Li, H. Li, R. Fan, B. Wen, J. Zhang, X. Cao, C. Wang, Z. Song, S. Li, X. Li, Coronavirus infections in the central nervous system and respiratory tract show distinct features in hospitalized children, Intervirology, 59 (2016) 163-169.
[13] W. Liang, W. Guan, R. Chen, W. Wang, J. Li, K. Xu, C. Li, Q. Ai, W. Lu, H. Liang, Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China, The Lancet Oncology, 21 (2020) 335-337.
[14] J. Ma, J. Yin, Y. Qian, Y. Wu, Clinical characteristics and prognosis in cancer patients with COVID-19: A single center's retrospective study, The Journal of Infection, (2020).
[15] L. Mao, H. Jin, M. Wang, Y. Hu, S. Chen, Q. He, J. Chang, C. Hong, Y. Zhou, D. Wang, Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China, JAMA neurology, 77 (2020) 683-690.
[16] N. Poyiadji, G. Shahin, D. Noujaim, M. Stone, S. Patel, B. Griffith, COVID-19–associated acute hemorrhagic necrotizing encephalopathy: CT and MRI features. Images Radiol, in, 2020.
[17] S.M. Rubinstein, J.L. Warner, COVID-19 and haematological malignancy: navigating a narrow strait, The Lancet Haematology, 7 (2020) e701-e703.
[18] C. Speth, J. Löffler, S. Krappmann, C. Lass-Flörl, G. Rambach, Platelets as immune cells in infectious diseases, Future microbiology, 8 (2013) 1431-1451.
[19] M. Taha, A. Sharma, A. Soubani, Clinical deterioration during neutropenia recovery after G-CSF therapy in patient with COVID-19, Respiratory medicine case reports, 31 (2020) 101231.
[20] A. Vijenthira, I.Y. Gong, T.A. Fox, S. Booth, G. Cook, B. Fattizzo, F. Martín-Moro, J. Razanamahery, J.C. Riches, J. Zwicker, Outcomes of patients with hematologic malignancies and COVID-19: a systematic review and meta-analysis of 3377 patients, Blood, The Journal of the American Society of Hematology, 136 (2020) 2881-2892.
[21] D. Wang, B. Hu, C. Hu, F. Zhu, X. Liu, J. Zhang, B. Wang, H. Xiang, Z. Cheng, Y. Xiong, Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China, Jama, 323 (2020) 1061-1069.
[22] H. Wang, L. Zhang, Risk of COVID-19 for patients with cancer, The Lancet. Oncology, 21 (2020) e181-e181.
[23] WHO, Report of the WHO-China joint mission on coronavirus disease 2019 (COVID-19), in, Geneva, 2020.
[24] Y. Wu, X. Xu, Z. Chen, J. Duan, K. Hashimoto, L. Yang, C. Liu, C. Yang, Nervous system involvement after infection with COVID-19 and other coronaviruses, Brain, behavior, and immunity, (2020).
[25] C.B. Yeoh, K.J. Lee, E.F. Rieth, R. Mapes, A.V. Tchoudovskaia, G.W. Fischer, L.E. Tollinche, COVID-19 in the Cancer Patient, Anesth Analg, 131 (2020) 16-23.
[26] J. Yu, W. Ouyang, M.L. Chua, C. Xie, SARS-CoV-2 transmission in patients with cancer at a tertiary care hospital in Wuhan, China, JAMA oncology, (2020).
[27] L. Zhang, F. Zhu, L. Xie, C. Wang, J. Wang, R. Chen, P. Jia, H. Guan, L. Peng, Y. Chen, Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, China, Annals of Oncology, (2020).